|
Model Number 3058 |
Device Problems
Failure to Interrogate (1332); Unintended Collision (1429); Energy Output Problem (1431); Therapy Delivered to Incorrect Body Area (1508); Communication or Transmission Problem (2896); Insufficient Information (3190)
|
Patient Problems
Undesired Nerve Stimulation (1980); Insufficient Information (4580)
|
Event Date 09/14/2022 |
Event Type
malfunction
|
Event Description
|
Information was received from a healthcare provider regarding a patient who was implanted with an implantable neurostimulator (ins) for urinary dysfunction/sacral nerve stimulation and gastrointestinal/pelvic floor.It was reported that patient getting error 505, invalid settings, on the patient programmer.Clinician said she couldn't connect to the implant, but when technical services (ts) had caller try again, she was finally able to connect.Impedance check was good, all electrodes were in the 1000 ohms range.Caller tried different electrode combinations but patient felt stimulation in the lower right buttock, neurostimulator is in upper right buttock.Caller said all electrode combinations with electrode 3 gave buttock stimulation.Ts then had caller move programming further down the lead but had the same result.Patient then mentioned that she fell earlier this year and stimulation did change after the fall.Ts told caller that even though impedance check was good, but questioned whether the fall might have moved the lead enough that it affected stimulation sensation/location.During the call the 8840 clinician programmer lost connection to the implant, and no matter how the clinician programmer antenna was position, the healthcare provider (hcp) couldn't reconnect to the implant.Ts told caller that implant battery issue is suspected given that device kept disconnecting just as it did when clinician originally tried to connect to the implant.Supposedly longevity was 62-73 months as of jan 2021 interrogation.The issue was not resolved through troubleshooting.
|
|
Manufacturer Narrative
|
This regulatory report is being submitted as part of a retrospective review as part of remediation plan 411.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Search Alerts/Recalls
|
|
|